Crude Oil Futures Lower During the European Session By Investing.com

Crude Oil Futures Lower During the European Session By Investing.com
Crude Oil Futures Lower During the European Session By Investing.com

© Reuters. Crude oil futures fell during the European session

Investing.com – It fell during the European session on Friday.

According to the New York Mercantile Exchange, trading took place in November at USD74.39 per barrel at the time of writing, down by 0.85%.

The session has already been traded lower than USD74.22 per barrel. It may find support points at USD73.16 and resistance at USD76.67.

The dollar index, which measures the performance of the US currency against a basket of six other major currencies, fell 0.17% to trade at USD94.078.

Meanwhile on Nymex, the price for the month of December fell by 0.64% to be traded at USD77.81 per barrel, while the spread (spread) between contracts stood at USD3.42 per barrel.

Explanation of the risks: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source

Crude Oil Futures European Session Investingcom

 
For Latest Updates Follow us on Google News
 

PREV Daimler shareholders agree to separate the truck and luxury car segments
NEXT European Medicines Agency: A possible link between Johnson’s vaccine and rare blood clots